AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.

Biotechnology

AVM Biotech

AVM Biotech's headquarters in Seattle, WA, United States

Theresa A. Deisher, Ph.D.

Siuliana Limasi

Jena Dalpez

Gordon Roble, D.V.M.

Frank Buttgereit, M.D.

Edward Loniewski, D.O.

Gustavo Mahler, Ph.D.

Gianpietro Dotti

William Matsui, M.D.

The Research & Development team at AVM Biotech is dedicated to pioneering innovative stem cell technologies and advancing contributions to regenerative medicine and personalized treatment. Comprising scientific advisors and researchers, the team focuses on designing and conducting experiments, analyzing results, and collaborating with clinical experts to ensure the effective development and commercialization of bespoke biologics for patients with unmet medical needs. Their work is essential in transforming laboratory breakthroughs into viable therapeutic solutions.

Research & Development

The Leadership Team at AVM Biotech is dedicated to strategic direction and oversight of the company's innovative initiatives in stem cell technologies and personalized medicine. They focus on fostering relationships with investors, guiding scientific research and development, and ensuring alignment with the company's mission to address unmet medical needs through advanced biotech solutions. Their expertise helps shape the future of regenerative medicine and the commercialization of bespoke therapeutic products.

AVM Biotech

Org chart

Board & advisors

Teams

Research & Development

Leadership Team

Offices

AVM Biotech

Org chart

Board & advisors

Teams

Research & Development

Leadership Team

Offices

Related companies